Fiduciary Trust CO Repligen Corp Transaction History

Fiduciary Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $170 - $208	-1 Reduced 0.06%	1,699 $312,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $90,207 - $114,731	-650 Reduced 27.66%	1,700 $270,000
Q2 2023 Aug 01, 2023	SELL	$138.42 - $180.31 $2,353 - $3,065	-17 Reduced 0.72%	2,350 $332,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $2,761 - $3,749	17 Added 0.72%	2,367 $400,000
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $8,020 - $12,810	-50 Reduced 2.08%	2,350 $440,000
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $80,595 - $128,979	500 Added 26.32%	2,400 $451,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $24,759 - $30,447	-100 Reduced 5.0%	1,900 $503,000
Q1 2021 May 19, 2021	BUY	$180.37 - $226.26 $360,740 - $452,520	2,000 New	2,000 $389,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.